Metrikler
Yayın
37
Açık Erişim
7
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
2000 - 2002
2000 - 2002Tıpta Yandal Uzmanlık
The University Of Texas Md Anderson Cancer Center, Dept. Of Blood And Marrow Transplantation, Amerika Birleşik Devletleri
1997 - 2000
1997 - 2000Tıpta Yandal Uzmanlık
University of Cincinnati, School Of Medicine, Dept. Of Internal Medicine Division Of Hematology-Oncology, Amerika Birleşik Devletleri
1992 - 1997
1992 - 1997Tıpta Uzmanlık
Ege Üniversitesi, Tıp Fakültesi, İç Hastalıkları Abd, Türkiye
1985 - 1992
1985 - 1992Lisans
Hacettepe Üniversitesi, Tıp Fakültesi (İngilizce), Türkiye
Yabancı Diller
C1 İleri
C1 İleriİngilizce
Araştırma Alanları
Tıp
Sağlık Bilimleri
Dahili Tıp Bilimleri
İç Hastalıkları
Hematoloji
Onkoloji
Akademik Faaliyetlere Dayalı Araştırma Alanları
Avesis Araştırma Alanları
WoS Araştırma Alanları
Scopus Araştırma Alanları
Makaleler
Tümü (30)
SCI-E, SSCI, AHCI (30)
SCI-E, SSCI, AHCI, ESCI (30)
Scopus (30)
TRDizin (6)
2020
20201. Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor - A Multicenter Cohort Study
OKAY M., Aslan T., Ozdemir E., ÜNER A., Saglam A., Gungor E., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.37, sa.2, ss.84-90, 2020 (SCI-Expanded, Scopus, TRDizin)
2018
20182. Automated washing of long-term cryopreserved peripheral blood stem cells promotes cell viability and preserves CD34+cell numbers
Aerts-Kaya F. S. F., Koca G., Sharafi P., Sayla F. C., Uckan-Cetinkaya D., Ozdemir E.
BONE MARROW TRANSPLANTATION
, cilt.53, sa.9, ss.1225-1227, 2018 (SCI-Expanded, Scopus)
2018
20183. Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin lymphoma (HL): Impact of cycle 2 PET result on modified progression-free survival (mPFS).
Chen R. W., Ansell S. M., Gallamini A., Connors J. M., Savage K. J., Collins G. P., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.36, sa.15, 2018 (SCI-Expanded, Scopus)
2017
20174. Successful treatment of relapsed/refractory Hodgkins lymphoma with nivolumab in a heavily pretreated patient with progressive disease after both autologous and allogeneic stem cell transplantation
Aslan A., Aras T., ÖZDEMİR E.
LEUKEMIA & LYMPHOMA
, cilt.58, sa.3, ss.754-755, 2017 (SCI-Expanded, Scopus)
2016
20165. Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Daily Practice: A Multicenter Experience
Tekgunduz E., GÖKER H., KAYNAR L., SARI İ., Pala C., Dogu M. H., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, cilt.16, sa.5, ss.269-274, 2016 (SCI-Expanded, Scopus)
2016
20166. Anthracyclin - Based Chemotherapy in Patients with Non-Hodgkin Lymphoma Aged Over 75
Sarici F., KERTMEN N., Aslan A. C., Tasdemir V., BABACAN T., KILIÇKAP S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.26, sa.2, ss.89-95, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
20167. Idelalisib at the Crossroads of B-Cell Lymphoproliferative Disorders
AKSU S., Ayyildiz O., ETGÜL S., GÖKER H., GÜNEŞ G., HAZNEDAROĞLU İ. C., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.26, sa.1, ss.12-19, 2016 (SCI-Expanded, Scopus, TRDizin)
2014
20148. Potential drug interactions and side effects in an outpatient oncology clinic: a retrospective descriptive study
Bayraktar-Ekincioglu A., Demirkan K., KESKIN B., ASLANTAS O., Ozdemir E.
EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE
, cilt.21, sa.4, ss.216-221, 2014 (SCI-Expanded, Scopus)
2014
20149. Ibrutinib: From Molecule to Medicine
Ayyildiz O., Demirkan F., GÖKER H., HAZNEDAROĞLU İ. C., Ilhan O., KAYNAR L., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.24, sa.3, ss.4-14, 2014 (SCI-Expanded, Scopus, TRDizin)
2013
201310. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: A single center experience
GÖKER H., Ozdemir E., UZ B., BÜYÜKAŞIK Y., Turgut M., SEREFHANOGLU S., et al.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.49, sa.3, ss.590-599, 2013 (SCI-Expanded, Scopus)
2013
201311. Deep Vein Thrombosis Following Non-myeloablative Allogeneic Stem Cell Transplantation: Presentation of Three Cases and Literature Review
Ozdemir E., Kansu E.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.30, sa.2, ss.188-190, 2013 (SCI-Expanded, Scopus, TRDizin)
2013
201312. The effect of granulocyte colony stimulating factor receptor gene missense single nucleotide polymorphisms on peripheral blood stem cell enrichment
CAMURDANOGLU B. Z., ESENDAĞLI G., Ozdemir E., CANPINAR H., Guc D., Kansu E.
CYTOKINE
, cilt.61, sa.2, ss.572-577, 2013 (SCI-Expanded, Scopus)
2013
201313. Hyper-CVAD Regimen in Routine Management of Adult Acute Lymphoblastic Leukemia: A Retrospective Multicenter Study
BÜYÜKAŞIK Y., Acar K., Kelkitli E., UZ B., SEREFHANOGLU S., Ozdemir E., et al.
ACTA HAEMATOLOGICA
, cilt.130, sa.3, ss.199-205, 2013 (SCI-Expanded, Scopus)
2012
201214. Successful Treatment of Autoimmune Hemolytic Anemia with Steroid, IVIg, and Plasmapheresis in a Haploidentical Transplant Recipient
UZ B., Ozdemir E., Aksu S., AKYOL T. K., JONES R.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.29, sa.2, ss.199-200, 2012 (SCI-Expanded, Scopus, TRDizin)
2011
201115. Relationship between LYVE-1, VEGFR-3 and CD44 gene expressions and lymphatic metastasis in gastric cancer
ÖZMEN F., OZMEN M. M., Ozdemir E., MORAN M., SECKIN S., Guc D., et al.
WORLD JOURNAL OF GASTROENTEROLOGY
, cilt.17, sa.27, ss.3220-3228, 2011 (SCI-Expanded, Scopus)
2011
201116. Acute promyelocytic leukemia in a young patient with breast cancer
KARA O., Ozdemir E., Arslan C., DOGAN E., ALTUNDAG K.
MEDICAL ONCOLOGY
, cilt.28, sa.1, ss.249-250, 2011 (SCI-Expanded, Scopus)
2010
201017. Mechanisms behind the anti-tumour effects of zoledronic acid use in multiple myeloma
ARARAT E., SAHIN I., Ozdemir E., ALTUNDAG K.
BRITISH JOURNAL OF HAEMATOLOGY
, cilt.151, sa.5, ss.530-531, 2010 (SCI-Expanded, Scopus)
2010
201018. Clinical features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and anthracyclines (PETHEMA protocol) therapy
SEREFHANOGLU S., BÜYÜKAŞIK Y., GÖKER H., SAYINALP N., HAZNEDAROĞLU İ. C., AKSU S., et al.
LEUKEMIA RESEARCH
, cilt.34, sa.12, 2010 (SCI-Expanded, Scopus)
2010
201019. Late relapse of acute myeloblastic leukemia as myeloid sarcoma causing radiculopathy
FIRAT F., OZEN G., YILDIZ G., SAGLAM A., ONDER S., TAN E., et al.
LEUKEMIA RESEARCH
, cilt.34, sa.12, 2010 (SCI-Expanded, Scopus)
2010
201020. Breast Cancer in a Patient with Agnogenic Myeloid Metaplasia
ARIK Z., OZKAN C., Ozdemir E., ALTUNDAG K.
SOUTHERN MEDICAL JOURNAL
, cilt.103, sa.10, ss.1075-1076, 2010 (SCI-Expanded, Scopus)
2009
200921. High complete remission rate and durable remissions achieved with rational use of autologous stem-cell transplantation, thalidomide maintenance, and non-myeloablative allogeneic transplantation in patients with multiple myeloma
Oyan B., KOC Y., Ozdemir E., KARS A., TURKER A., TEKUZMAN G., et al.
CLINICAL TRANSPLANTATION
, cilt.23, sa.6, ss.839-847, 2009 (SCI-Expanded, Scopus)
2009
200922. Late relapse of a light-chain myeloma as extramedullary plasmacytoma of the thyroid gland after second allogeneic stem-cell transplantation
Ozdemir E., BAYRAKTAR M., SÖKMENSÜER C., Kir K. M., Kansu E.
CLINICAL TRANSPLANTATION
, cilt.23, sa.6, ss.981-984, 2009 (SCI-Expanded, Scopus)
2008
200823. The Lollipop with Strawberry Aroma May Be Promising in Reduction of Infusion-Related Nausea and Vomiting during the Infusion of Cryopreserved Peripheral Blood Stem Cells
Ozdemir E., AKGEDIK K., AKDOGAN S., Kansu E.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
, cilt.14, sa.12, ss.1425-1428, 2008 (SCI-Expanded, Scopus)
2006
200624. High dose sequential chemotherapy and autologous stem cell transplantation in patients with relapsed/refractory lymphoma
OYAN B., KOC Y., Ozdemir E., KARS A., TURKER A., TEKUZMAN G., et al.
LEUKEMIA & LYMPHOMA
, cilt.47, sa.8, ss.1545-1552, 2006 (SCI-Expanded, Scopus)
2006
200625. Successful treatment of chronic myeloid leukemia with imatinib mesylate in a patient with chronic renal failure on hemodialysis
Ozdemir E., KOC Y., KANSU E.
AMERICAN JOURNAL OF HEMATOLOGY
, cilt.81, sa.6, ss.474, 2006 (SCI-Expanded, Scopus)
2006
200626. Hookworm infection of sigmoid colon masquerading as graft-versus-host disease in an allogeneic stem cell transplant recipient after donor lymphocyte infusion for refractory acute promyelocytic leukemia
Ozdemir E., MOLLDREM J.
BONE MARROW TRANSPLANTATION
, cilt.37, sa.8, ss.785-786, 2006 (SCI-Expanded, Scopus)
2005
200527. Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-hodgkin lymphoma: A salvage regimen with high response rates before autologous stem cell transplantation
OYAN B., KOC Y., Ozdemir E., KARS A., TURKER A., TEKUZMAN G., et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
, cilt.11, sa.9, ss.688-697, 2005 (SCI-Expanded, Scopus)
2002
200228. Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8(+) T cells
Ozdemir E., ST JOHN L., GILLESPIE G., ROWLAND-JONES S., CHAMPLIN R., MOLLDREM J., et al.
BLOOD
, cilt.100, sa.10, ss.3690-3697, 2002 (SCI-Expanded, Scopus)
1998
199829. Two consecutive spontaneous regressions to chronic phase in a patient with blastic transformation of chronic myelogenous leukemia
CAGIRGAN S., SENCAN M., TOMBULOGLU M., Ozdemir E., HEKIMGIL M., BUYUKKECECI F.
LEUKEMIA & LYMPHOMA
, cilt.29, ss.423-425, 1998 (SCI-Expanded, Scopus)
1998
199830. Focal myositis
KOCANAOGULLARI H., Ozdemir E., KESER G., TUNCBAY T., GUMUSDIS G., DOGANAVSARGIL E.
CLINICAL RHEUMATOLOGY
, cilt.17, sa.1, ss.65-67, 1998 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2015
20151. Gemcitabine in Combination with Oxaliplatin (GEMOX) As a Salvage Regimen in Patients with Relapsed/Refractory Hodgkin's Lymphoma
ÖZDEMİR E., Aslan A., Turker A., BARIŞTA İ., Kars A.
57th Annual Meeting of the American-Society-of-Hematology, Florida, Amerika Birleşik Devletleri, 5 - 08 Aralık 2015, cilt.126, (Özet Bildiri)
2015
20152. Single Agent Gemcitabine As a Salvage Regimen in Patients with Relapsed/Refractory Hodgkin's Lymphoma after Autologous Stem Cell Transplantation
ÖZDEMİR E., Aslan A., Turker A., BARIŞTA İ., Kars A.
57th Annual Meeting of the American-Society-of-Hematology, Florida, Amerika Birleşik Devletleri, 5 - 08 Aralık 2015, cilt.126, (Özet Bildiri)
2015
20153. The retrospective analysis of central nervous system lymphomas: Single-center experience.
Sunar V., Yasar A., Sarici F., Esin E., Diker O., Lacin S., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)
2014
20144. Lower Doses of Plerixafor Use Is Sufficient to Effectively Mobilize PBSC (Peripheral Blood Hematopoetic Stem Cells) When Compared to Standard Administration
GÖKER H., ELİAÇIK E., Altuntas F., Tekgunduz E., ÖZDEMİR E., Isik A., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124, (Özet Bildiri)
2014
20145. HODGKIN'S LYMPHOMA: DIAGNOSIS AND STAGING
ÖZDEMİR E.
5th International Eurasian Hematology Congress, Antalya, Türkiye, 15 - 19 Ekim 2014, cilt.38, (Özet Bildiri)
2013
20136. High-dose chemotherapy and autologous stem cell transplantation in refractory/metastatic nonseminomatous germ cell-tumors: A retrospective study of the Turkish Oncology Association.
Ozturk M., Arpaci F., Ozaydin S., Karadurmus N., Ozdemir E., Ataergin S., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)
2007
20077. Bortezomib, dexamethasone and concomitant or sequential thalidomide (VTD): An effective combination for relapsed/refractory multiple myeloma failing thalidomide and dexamethasone
ÖZDEMİR E., Koc Y., Kars A., Turker A., Tekuzman G., KANSU E.
49th Annual Meeting of the American-Society-of-Hematology, Georgia, Amerika Birleşik Devletleri, 8 - 11 Aralık 2007, cilt.110, (Özet Bildiri)
Desteklenen Projeler
2015 - 2016
2015 - 2016DMSO ile kriyoprezerve edilen hematopoietik kök hücrelerden DMSO uzaklaştırılmasının kök hücre sayı ve canlılığı üzerine etkisi
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
ÖZDEMİR E. (Yürütücü), KOCA G., AKBIYIK F., AYYILDIZ E., AYDOĞDU G., ÇAKMAK SAYLA F.